- Home
- FGEN vs CLIR Comparison
FGEN vs CLIR Comparison
Compare FGEN & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- CLIR
- Stock Information
- Founded
- FGEN 1993
- CLIR 2008
- Country
- FGEN United States
- CLIR United States
- Employees
- FGEN N/A
- CLIR N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- CLIR Industrial Machinery/Components
- Sector
- FGEN Health Care
- CLIR Industrials
- Exchange
- FGEN Nasdaq
- CLIR Nasdaq
- Market Cap
- FGEN 33.5M
- CLIR 27.9M
- IPO Year
- FGEN 2014
- CLIR 2012
- Fundamental
- Price
- FGEN $7.69
- CLIR $0.54
- Analyst Decision
- FGEN Strong Buy
- CLIR Strong Buy
- Analyst Count
- FGEN 1
- CLIR 1
- Target Price
- FGEN $250.00
- CLIR $2.00
- AVG Volume (30 Days)
- FGEN 74.7K
- CLIR 55.2K
- Earning Date
- FGEN 08-05-2025
- CLIR 08-13-2025
- Dividend Yield
- FGEN N/A
- CLIR N/A
- EPS Growth
- FGEN N/A
- CLIR N/A
- EPS
- FGEN N/A
- CLIR N/A
- Revenue
- FGEN $6,996,000.00
- CLIR $2,895,000.00
- Revenue This Year
- FGEN N/A
- CLIR $27.61
- Revenue Next Year
- FGEN N/A
- CLIR $116.19
- P/E Ratio
- FGEN N/A
- CLIR N/A
- Revenue Growth
- FGEN N/A
- CLIR 10.88
- 52 Week Low
- FGEN $4.50
- CLIR $0.46
- 52 Week High
- FGEN $38.25
- CLIR $1.72
- Technical
- Relative Strength Index (RSI)
- FGEN 63.73
- CLIR 38.87
- Support Level
- FGEN $5.37
- CLIR $0.50
- Resistance Level
- FGEN $5.73
- CLIR $0.60
- Average True Range (ATR)
- FGEN 0.51
- CLIR 0.06
- MACD
- FGEN 0.32
- CLIR -0.00
- Stochastic Oscillator
- FGEN 97.26
- CLIR 26.77
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.